title: Kaposi varicelliform eruption associated with 0.1% tacrolimus ointment treatment in atopic blepharitis.
abstract: OBJECTIVE
  To report the association of Kaposi varicelliform eruption (KVE) with 0.1% tacrolimus ointment treatment of atopic blepharitis in a patient with atopic dermatitis (AD).
  
  
  METHODS
  We encountered KVE in a 20-year-old male patient with atopic blepharitis and AD who developed generalized herpetic lesions on his face 28 days after commencement of treatment.
  
  
  RESULTS
  The lesions resolved quickly with intravenous acyclovir treatment.
  
  
  CONCLUSIONS
  Ophthalmologists should be well aware of KVE as a complication of immunosuppressive treatment in patients with atopic blepharitis.
authors.affiliation: Department of Ophthalmology, Tokyo Dental College, Chiba 272-8513, Japan. minori.miyake@nifty.ne.jp
authors.forename: Minori
authors.initials: M
authors.lastname: Miyake-Kashima
authors.forename: Kazumi
authors.initials: K
authors.lastname: Fukagawa
authors.forename: Mari
authors.initials: M
authors.lastname: Tanaka
authors.forename: Yoji
authors.initials: Y
authors.lastname: Takano
authors.forename: Murat
authors.initials: M
authors.lastname: Dogru
authors.forename: Naoko
authors.initials: N
authors.lastname: Asano-Kato
authors.forename: Shin-Ichi
authors.initials: S
authors.lastname: Takahashi
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Fujishima
mesh_terms: D000212:Acyclovir / Q000627:therapeutic use; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D001762:Blepharitis / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007617:Kaposi Varicelliform Eruption / Q000139:chemically induced* / Q000188:drug therapy; D008297:Male; D009824:Ointments; D016559:Tacrolimus / Q000009:adverse effects*; D014775:Virus Activation / Q000187:drug effects
chemical_list: D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D009824:Ointments; D016559:Tacrolimus; D000212:Acyclovir